| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/07/2011 | CA2776501A1 Fibroblast growth patterns for diagnosis of alzheimer's disease |
| 04/07/2011 | CA2776498A1 Abnormal alterations of pkc isozymes processing in alzheimer's disease peripheral cells |
| 04/07/2011 | CA2776278A1 Biomarkers for predicting the sensitivity and response of protein kinase ck2-mediated diseases to ck2 inhibitors |
| 04/07/2011 | CA2776149A1 Genes, methods, and compositions related to neurogenesis and its modulation |
| 04/07/2011 | CA2775978A1 Marker sequences for pancreatic cancer diseases, pancreatic carcinoma and use thereof |
| 04/07/2011 | CA2775889A1 Method for detecting single nucleotide polymorphisms |
| 04/07/2011 | CA2775685A1 Monoclonal antibody against human hig-1 polypeptide |
| 04/07/2011 | CA2775067A1 Detection of markers in pressurized hydrocarbon fluids |
| 04/07/2011 | CA2774869A1 Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis |
| 04/07/2011 | CA2774778A1 Analyte sensor apparatuses having interference rejection membranes and methods for making and using them |
| 04/07/2011 | CA2774256A1 Monoclonal antibodies |
| 04/07/2011 | CA2773882A1 A-fucosylation detection in antibodies |
| 04/07/2011 | CA2684266A1 Breath test simulator and method |
| 04/06/2011 | EP2306233A2 Optical scanning system comprising thermally compensated light emitting diode |
| 04/06/2011 | EP2306204A1 Nucleic acid analyzer, automatic analyzer, and analysis method |
| 04/06/2011 | EP2306203A1 Diagnosis and risk stratification using NT-proET-1 |
| 04/06/2011 | EP2306202A1 Method of detecting or monitoring a malignant plasma cell disease |
| 04/06/2011 | EP2306201A1 Methods and compositions for assaying homocysteine |
| 04/06/2011 | EP2306200A1 Apoptosis sensitivity to Apo2L/TRAILl by testing for GalNac-T14 expression in cells/tissues |
| 04/06/2011 | EP2306199A1 Reductive amination and analysis of carbohydrates using 2-picoline borane as reducing agent |
| 04/06/2011 | EP2306198A1 Method of analyzing protein structural affinity relationship |
| 04/06/2011 | EP2306197A1 Biochip substratum and method for production thereof |
| 04/06/2011 | EP2306196A1 Adhesive compositon for use in an immunosensor |
| 04/06/2011 | EP2306195A2 Biological applications of semiconductor nanocrystals |
| 04/06/2011 | EP2306194A1 Developing solution for immunochromatography, and measurement method using same |
| 04/06/2011 | EP2306193A2 Method for detecting molecules clinging to a lure and molecules clinging specifically to a lure and their use |
| 04/06/2011 | EP2306192A2 Risk Markers For Cardiovascular Disease |
| 04/06/2011 | EP2306191A1 Use of CD154 for the identification and separation of non-regulatory T-cells from a mixture of regulatory T-cells |
| 04/06/2011 | EP2306190A1 Method for measuring target component in erythrocyte-containing specimen |
| 04/06/2011 | EP2306189A1 Multiwell plate assembly for use in high throughput assays |
| 04/06/2011 | EP2306188A1 Cell dispersion method, cell dispersing agent, and cell measurement method |
| 04/06/2011 | EP2306187A1 Cancer eradication program |
| 04/06/2011 | EP2306182A1 Ion sensor, ion sensor module, and ion sensor manufacturing method |
| 04/06/2011 | EP2306177A1 Method for measurement of physiologically active substance derived from organism and measurement apparatus |
| 04/06/2011 | EP2306174A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2306173A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2306158A1 Fluid detector with two-part housing |
| 04/06/2011 | EP2305836A1 Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer |
| 04/06/2011 | EP2305833A2 Markers for detection of gastric cancer |
| 04/06/2011 | EP2305832A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2305830A2 Method for evaluation of compound using RSK1 |
| 04/06/2011 | EP2305829A2 Method for screening for skin wrinkling- and sagging-improving agents using skin cells |
| 04/06/2011 | EP2305828A1 Electrode with thin working layer |
| 04/06/2011 | EP2305827A1 Cancer antigen MAGE-A9 and uses thereof |
| 04/06/2011 | EP2305823A1 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 04/06/2011 | EP2305818A2 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 04/06/2011 | EP2305817A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 04/06/2011 | EP2305816A1 Mutation in the Parkin gene, compositions, methods and uses |
| 04/06/2011 | EP2305813A2 Fuctional and hyperfunctional sirna |
| 04/06/2011 | EP2305812A2 Fuctional and hyperfunctional sirna |
| 04/06/2011 | EP2305808A1 Templated molecules and methods for using such molecules |
| 04/06/2011 | EP2305807A1 Method for detecting or quantifying dna |
| 04/06/2011 | EP2305806A1 Method for detecting or quantifying dna |
| 04/06/2011 | EP2305802A1 Modified vitamin K-dependent polypeptides |
| 04/06/2011 | EP2305794A1 Expansion of renewable stem cell populations |
| 04/06/2011 | EP2305775A2 Functionalized fluorescent nanocrystals, and methods for their preparation and use |
| 04/06/2011 | EP2305717A1 Inhibiting TNIK for treating colon cancer |
| 04/06/2011 | EP2305714A2 Anti-interferon-alpha subtypes antibodies |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305710A2 Synthetic antibody phage libraries |
| 04/06/2011 | EP2305708A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 04/06/2011 | EP2305707A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 04/06/2011 | EP2305706A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 04/06/2011 | EP2305704A1 Fucose 1 6-specific lectin |
| 04/06/2011 | EP2305701A1 Tuberculosis antigen detection assays and vaccines |
| 04/06/2011 | EP2305700A1 Therapeutic USPA1-derived peptides |
| 04/06/2011 | EP2305692A1 Method for releasing and labelling O-glycans |
| 04/06/2011 | EP2305690A1 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 04/06/2011 | EP2305597A1 Production method for a nanopatterned epoxy substrate |
| 04/06/2011 | EP2305302A2 Prevention and treatment of amyloidogenic disease |
| 04/06/2011 | EP2305301A2 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/06/2011 | EP2305282A2 Prevention and treatment of amyloidogenic disease |
| 04/06/2011 | EP2305264A1 Spicamycin derivatives for use in decreasing or preventing pain |
| 04/06/2011 | EP2305242A2 20-carboxy-(S)-trioxilin A3 for treating neurologic disorders |
| 04/06/2011 | EP2305236A1 Means of Ascertaining an Individual's Risk Profile for Atherosclerotic Disease |
| 04/06/2011 | EP2305235A1 Means of ascertaining an individual's risk profile for atherosclerotic disease |
| 04/06/2011 | EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 04/06/2011 | EP2305173A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2305172A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2305171A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2305113A1 Biometric measurement apparatus |
| 04/06/2011 | EP2305102A1 Analyte measurement |
| 04/06/2011 | EP2304624A1 Model system for diagnosing lipid metabolism |
| 04/06/2011 | EP2304444A1 Modulators of stat3 signalling |
| 04/06/2011 | EP2304443A2 H-fabp as a marker for myocardial hibernation |
| 04/06/2011 | EP2304442A1 Blood serum marker for detection and diagnosis of alzheimer's disease |
| 04/06/2011 | EP2304441A2 A method for the screening of conserved secreted proteins |
| 04/06/2011 | EP2304440A1 Novel monoclonal antibodies against hpv proteins |
| 04/06/2011 | EP2304439A2 Anti-phospho-akt antibodies |
| 04/06/2011 | EP2304438A1 Assessment of complications of patients with type 1 diabetes |
| 04/06/2011 | EP2304437A1 Disease specific diagnostic aid |
| 04/06/2011 | EP2304436A1 Methods for diagnosis, prognosis and treatment |
| 04/06/2011 | EP2304435A1 Novel mitochondrial dye |
| 04/06/2011 | EP2304434A2 Protein biomarkers for in vitro testing of developmental toxicity and embryotoxicity of chemical substances |
| 04/06/2011 | EP2304433A1 Dynamic light scattering for in vitro testing of bodily fluids |
| 04/06/2011 | EP2304432A2 Hand-held analysis appliance for analysing a body fluid, and method for controlling said appliance |
| 04/06/2011 | EP2304431A1 Csf biomarkers for the prediction of cognitive decline in alzheimer's disease patients |
| 04/06/2011 | EP2304430A2 Method for preventing a vehicle engine from running |
| 04/06/2011 | EP2304429A1 Method of monitoring and optimizing additive concentration in fuel ethanol |